This inventor holds 2 USPTO granted patents. Top assignee: Vanderbilt University. Active years: 2014-2015.
Company Filing History:
Years Active: 2014-2015
Title: Josiane Eid: Innovator in Cancer Treatment
Introduction
Josiane Eid is a prominent inventor based in Nashville, TN (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on the development of monoclonal antibodies aimed at inhibiting WNT-mediated signaling pathways.
Latest Patents
Her latest patents include "Methods of using an antibody to inhibit WNT-mediated signaling in cancer" and "Methods of using an antibody to inhibit WNT-mediated cardiac remodeling." These inventions are directed to monoclonal antibodies and fragments thereof that target LRP5/6, which are crucial in the prevention and treatment of cardiac remodeling and cancer. The patents disclose methods for utilizing these monoclonal antibodies effectively in combating such diseases.
Career Highlights
Josiane Eid is affiliated with Vanderbilt University, where she conducts her research and develops her innovative solutions. Her work has garnered attention for its potential impact on cancer therapies and cardiac health.
Collaborations
Some of her notable coworkers include Ethan Lee and Pampee P Young, who contribute to her research endeavors and collaborative projects.
Conclusion
Josiane Eid's contributions to the field of cancer treatment through her patented inventions highlight her role as a leading innovator. Her work continues to pave the way for advancements in medical therapies.